Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

Also called NCT02380794

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 107 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02380794
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Hong Kong SAR China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02380794. Randomized; triple masking; primary purpose treatment. Start 2015-10-28 (actual); primary completion 2017-06-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
Condition
Peripheral Arterial Disease
Intervention (Drug)
Danshen Gegen Capsule
Intervention (Drug)
Placebo
Lead sponsor
Chinese University of Hong Kong (class: other)

Record details

Record id
cardio:ct-nct02380794
Content hash
fd3f624067b0b83dddf5cfab35d5eae75932b3020f84f975fcc9688612de5b4c